Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Environ Sci Pollut Res Int
2020 Feb 01;275:5469-5481. doi: 10.1007/s11356-019-07322-0.
Show Gene links
Show Anatomy links
Assessment of the ecotoxicity of the pharmaceuticals bisoprolol, sotalol, and ranitidine using standard and behavioral endpoints.
Godoy AA
,
Domingues I
,
de Carvalho LB
,
Oliveira ÁC
,
de Jesus Azevedo CC
,
Taparo JM
,
Assano PK
,
Mori V
,
de Almeida Vergara Hidalgo V
,
Nogueira AJA
,
Kummrow F
.
???displayArticle.abstract???
The pharmaceuticals bisoprolol (BIS), sotalol (SOT), and ranitidine (RAN) are among the most consumed pharmaceuticals worldwide and are frequently detected in different aquatic ecosystems. However, very few ecotoxicity data are available in the literature for them. To help fill these data gaps, toxicity tests with the algae Raphidocelis subcapitata, the macrophyte Lemna minor, the cnidarian Hydra attenuata, the crustacean Daphnia similis, and the fish Danio rerio were performed for assessing the ecotoxicity of these pharmaceuticals. Standard, as well as non-standard endpoint, was evaluated, including the locomotor behavior of D. rerio larvae. Results obtained for SOT and RAN showed that acute adverse effects are not expected to occur on aquatic organisms at the concentrations at which these pharmaceuticals are usually found in fresh surface waters. On the other hand, BIS was classified as hazardous to the environment in the acute III category. Locomotor behavior of D. rerio larvae was not affected by BIS and RAN. A disturbance on the total swimming distance at the dark cycle was observed only for larvae exposed to the highest test concentration of 500 mg L-1 of SOT. D. similis reproduction was affected by BIS with an EC10 of 3.6 (0.1-34.0) mg L-1. A risk quotient (RQ) of 0.04 was calculated for BIS in fresh surface water, considering a worst-case scenario. To the best of our knowledge, this study presents the first chronic toxicity data with BIS on non-target organisms.
88881.132858/2016-01 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, UID/AMB/50017/2019 Ministério da Ciência, Tecnologia e Ensino Superior, Law 57/2017, of July 19 Ministério da Ciência, Tecnologia e Ensino Superior
Andrade,
Carbendazim exposure induces developmental, biochemical and behavioural disturbance in zebrafish embryos.
2016, Pubmed
Andrade,
Carbendazim exposure induces developmental, biochemical and behavioural disturbance in zebrafish embryos.
2016,
Pubmed
Barata,
Toxicity of binary mixtures of metals and pyrethroid insecticides to Daphnia magna Straus. Implications for multi-substance risks assessment.
2006,
Pubmed
Bergheim,
Biodegradability and ecotoxicitiy of tramadol, ranitidine, and their photoderivatives in the aquatic environment.
2012,
Pubmed
Besse,
Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation.
2008,
Pubmed
Bühring,
Pharmacokinetics and metabolism of bisoprolol-14C in three animal species and in humans.
1986,
Pubmed
Castiglioni,
Removal of pharmaceuticals in sewage treatment plants in Italy.
2006,
Pubmed
Escher,
Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach.
2006,
Pubmed
Feiner,
Sublethal effects of the beta-blocker sotalol at environmentally relevant concentrations on the New Zealand mudsnail Potamopyrgus antipodarum.
2014,
Pubmed
Ferrari,
Exposure of the main italian river basin to pharmaceuticals.
2011,
Pubmed
Gabet-Giraud,
Occurrence and removal of estrogens and beta blockers by various processes in wastewater treatment plants.
2010,
Pubmed
Ginebreda,
Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain).
2010,
Pubmed
Godoy,
Occurrence, ecotoxicological effects and risk assessment of antihypertensive pharmaceutical residues in the aquatic environment--A review.
2015,
Pubmed
,
Echinobase
Godoy,
Ecotoxicological effects, water quality standards and risk assessment for the anti-diabetic metformin.
2018,
Pubmed
,
Echinobase
Godoy,
Single and mixture toxicity of four pharmaceuticals of environmental concern to aquatic organisms, including a behavioral assessment.
2019,
Pubmed
,
Echinobase
Gros,
Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry.
2012,
Pubmed
Gunnarsson,
Evolutionary conservation of human drug targets in organisms used for environmental risk assessments.
2008,
Pubmed
Hernando,
Analysis by liquid chromatography-electrospray ionization tandem mass spectrometry and acute toxicity evaluation for beta-blockers and lipid-regulating agents in wastewater samples.
2004,
Pubmed
Houtman,
A multicomponent snapshot of pharmaceuticals and pesticides in the river Meuse basin.
2013,
Pubmed
Huerta-Fontela,
Occurrence and removal of pharmaceuticals and hormones through drinking water treatment.
2011,
Pubmed
Huerta-Fontela,
Fast liquid chromatography-quadrupole-linear ion trap mass spectrometry for the analysis of pharmaceuticals and hormones in water resources.
2010,
Pubmed
Isidori,
Effects of ranitidine and its photoderivatives in the aquatic environment.
2009,
Pubmed
Jauković,
Cardiovascular drugs in environmental waters and wastewaters: method optimization and real sample analysis.
2014,
Pubmed
Jonker,
Significance testing of synergistic/antagonistic, dose level-dependent, or dose ratio-dependent effects in mixture dose-response analysis.
2005,
Pubmed
Klančar,
Levels of pharmaceuticals in Slovene municipal and hospital wastewaters: a preliminary study.
2016,
Pubmed
Kot-Wasik,
Occurrence and seasonal variations of 25 pharmaceutical residues in wastewater and drinking water treatment plants.
2016,
Pubmed
Lahti,
Microbial transformation of pharmaceuticals naproxen, bisoprolol, and diclofenac in aerobic and anaerobic environments.
2011,
Pubmed
Lara-Martín,
Occurrence, distribution and partitioning of nonionic surfactants and pharmaceuticals in the urbanized Long Island Sound Estuary (NY).
2014,
Pubmed
Larsson,
Effluent from drug manufactures contains extremely high levels of pharmaceuticals.
2007,
Pubmed
Lee,
Determination of beta-blockers and beta2-agonists in sewage by solid-phase extraction and liquid chromatography-tandem mass spectrometry.
2007,
Pubmed
Lindim,
Evaluation of human pharmaceutical emissions and concentrations in Swedish river basins.
2016,
Pubmed
Loos,
EU-wide monitoring survey on emerging polar organic contaminants in wastewater treatment plant effluents.
2013,
Pubmed
López-Roldán,
Advanced monitoring of pharmaceuticals and estrogens in the Llobregat River basin (Spain) by liquid chromatography-triple quadrupole-tandem mass spectrometry in combination with ultra performance liquid chromatography-time of flight-mass spectrometry.
2010,
Pubmed
López-Serna,
Occurrence of 95 pharmaceuticals and transformation products in urban groundwaters underlying the metropolis of Barcelona, Spain.
2013,
Pubmed
Maszkowska,
Beta-blockers in the environment: part I. Mobility and hydrolysis study.
2014,
Pubmed
Maszkowska,
Beta-blockers in the environment: part II. Ecotoxicity study.
2014,
Pubmed
Maurer,
Elimination of beta-blockers in sewage treatment plants.
2007,
Pubmed
Meador,
Contaminants of emerging concern in a large temperate estuary.
2016,
Pubmed
Minguez,
Toxicities of 48 pharmaceuticals and their freshwater and marine environmental assessment in northwestern France.
2016,
Pubmed
Oliveira,
Multilevel assessment of ivermectin effects using different zebrafish life stages.
2016,
Pubmed
Oliveira,
Characterization of Pharmaceuticals and Personal Care products in hospital effluent and waste water influent/effluent by direct-injection LC-MS-MS.
2015,
Pubmed
Oosterhuis,
Prediction of concentration levels of metformin and other high consumption pharmaceuticals in wastewater and regional surface water based on sales data.
2013,
Pubmed
Palmgrén,
Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions.
2006,
Pubmed
Petrović,
Determination of 81 pharmaceutical drugs by high performance liquid chromatography coupled to mass spectrometry with hybrid triple quadrupole-linear ion trap in different types of water in Serbia.
2014,
Pubmed
Piram,
Photolysis of beta-blockers in environmental waters.
2008,
Pubmed
Radjenovic,
Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor.
2007,
Pubmed
Radjenović,
Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
2009,
Pubmed
Reh,
Occurrence and spatial distribution of organic micro-pollutants in a complex hydrogeological karst system during low flow and high flow periods, results of a two-year study.
2013,
Pubmed
Richmond,
A diverse suite of pharmaceuticals contaminates stream and riparian food webs.
2018,
Pubmed
Ruff,
Quantitative target and systematic non-target analysis of polar organic micro-pollutants along the river Rhine using high-resolution mass-spectrometry--Identification of unknown sources and compounds.
2015,
Pubmed
Sanches,
Lethal and sublethal toxicity of abamectin and difenoconazole (individually and in mixture) to early life stages of zebrafish.
2018,
Pubmed
Santos,
Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment.
2010,
Pubmed
Santos,
Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals.
2013,
Pubmed
Scheurer,
The challenge of analyzing beta-blocker drugs in sludge and wastewater.
2010,
Pubmed
Scott,
The effects of environmental pollutants on complex fish behaviour: integrating behavioural and physiological indicators of toxicity.
2004,
Pubmed
Stankiewicz,
Determination of selected cardiovascular active compounds in environmental aquatic samples--Methods and results, a review of global publications from the last 10 years.
2015,
Pubmed
Steele,
In vivo and in vitro assessment of cardiac beta-adrenergic receptors in larval zebrafish (Danio rerio).
2011,
Pubmed
Verlicchi,
Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment.
2012,
Pubmed
Wang,
Zebrafish beta-adrenergic receptor mRNA expression and control of pigmentation.
2009,
Pubmed